Description

4-(2,3-Dichlorophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine is a high-purity, advanced pharmaceutical intermediate of significant importance in modern drug discovery and development. This compound is valued for its role as a key building block in the synthesis of novel therapeutic agents, particularly those targeting the central nervous system. It is primarily sought by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers engaged in the production of innovative active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly for neurological and psychiatric disorders.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Active Pharmaceutical Ingredient (API) Synthesis: Serves as a core scaffold for the manufacturing of complex, target-specific APIs.
• Biochemical Research: Employed as a reference standard or probe compound in pharmacological assays and target validation studies.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.

Basic Information

Product Name	4-(2,3-Dichlorophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine
CAS No.	1010918-36-1
Molecular Formula	C12H11Cl2N3
Molecular Weight	268.14 g/mol
Synonyms	4-(2,3-Dichlorophenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine; 4,5,6,7-Tetrahydro-4-(2,3-dichlorophenyl)-3H-imidazo[4,5-c]pyridine; 1010918-36-1; Imidazo[4,5-c]pyridine, 4-(2,3-dichlorophenyl)-4,5,6,7-tetrahydro-; 4-(2,3-Dichlorophenyl)-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine
EINECS	Contact for details

Quality Control

Our production of 4-(2,3-Dichlorophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine adheres to stringent quality management systems, ensuring batch-to-batch consistency and high purity. All materials undergo rigorous analytical testing, including HPLC, NMR, and MS, to confirm identity, potency, and impurity profiles. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing all specifications and test results. We support development under cGMP guidelines for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.